| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 29 |
| 1 | METHOTREXATE | 29 |
| 2 | METHOTREXATE SODIUM | 29 |
| 3 | HYDROXYCHLOROQUINE SULFATE | 28 |
| 4 | PREDNISONE | 28 |
| 5 | RIVAROXABAN | 28 |
| 6 | SULFASALAZINE | 27 |
| 7 | RITUXIMAB | 24 |
| 8 | WARFARIN | 23 |
| 9 | LEVONORGESTREL | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AZATHIOPRINE SODIUM | 11 | 0.0043 |
| 1 | CHORIONIC GONADOTROPIN | 2 | 0.0036 |
| 2 | CHORIOGONADOTROPIN ALFA | 7 | 0.0027 |
| 3 | CLOMIPHENE CITRATE | 4 | 0.0027 |
| 4 | GANIRELIX ACETATE | 2 | 0.0026 |
| 5 | MENOTROPINS | 4 | 0.0018 |
| 6 | CETRORELIX ACETATE | 1 | 0.0016 |
| 7 | NORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0011 |
| 8 | FOLLITROPIN ALFA | 2 | 0.0010 |
| 9 | ALMOTRIPTAN | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 39 |
| 1 | Corticosteroid [EPC] | 33 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 29 |
| 3 | Factor Xa Inhibitor [EPC] | 28 |
| 4 | Aminosalicylate [EPC] | 27 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 24 |
| 6 | Progestin-containing Intrauterine System [EPC] | 22 |
| 7 | Purine Antimetabolite [EPC] | 16 |
| 8 | Estrogen [EPC] | 11 |
| 9 | Copper-containing Intrauterine Device [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gonadotropin [EPC] | 2 | 0.0009 |
| 1 | Aminosalicylate [EPC] | 27 | 0.0003 |
| 2 | Purine Antimetabolite [EPC] | 16 | 0.0002 |
| 3 | Copper-containing Intrauterine Device [EPC] | 7 | 0.0001 |
| 4 | Progestin [EPC] | 39 | 0.0001 |
| 5 | Factor Xa Inhibitor [EPC] | 28 | 0.0001 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 24 | 0.0001 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 29 | 0.0001 |
| 8 | Estrogen [EPC] | 11 | 0.0001 |
| 9 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |